WASHINGTON – The U.S. Food and Drug Administration has officially warned a company about the illegal marketing and selling of products for opioid withdrawal.
The products are sold under the names Detoxoplex, Sinoplex and Migrenza.
According to EPH Technologies’ website, Detoxoplex can reduce “symptoms typically associated with withdrawal from opioid use.”
On Tuesday, the FDA sent a warning letter to EPH tTchnologies saying in part:
“This product has not been determined by FDA to be safe and effective for these uses. Further, this unproven treatment could cause patients to forgo or delay FDA-approved treatments for opioid addiction and withdrawal.”
Typically, symptoms of opioid withdrawal, including anxiety, nausea, vomiting and diarrhea.
It can be managed with medically assisted treatments such as Buprenorphine or Methadone.